Form 4: StableX Director Joseph Zvi Granted Stock Options

StableX Technologies Director Joseph Zvi received 22,723 employee stock options with an exercise price of $6.25, vesting partially immediately and the remainder by year-end.

Summary

• Joseph Zvi, a Director of StableX Technologies, Inc. (SBLX), was granted 22,723 employee stock options.
• The options have an exercise price of $6.25 per share.
• The grant date and earliest transaction date was October 31, 2025.
• The options are set to expire on October 31, 2035.
• The vesting schedule dictates that 75% (17,042 options) vested immediately on October 31, 2025.
• The remaining 25% (5,681 options) will vest on December 31, 2025, contingent on Joseph Zvi's continued employment or service to the Issuer.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a standard compensation practice that aligns the director's interests with shareholder value creation, which is generally viewed positively, though it's a routine disclosure rather than a significant market event.

Positives

• The grant of stock options to a director aligns their financial interests with those of shareholders, incentivizing long-term company performance.
• The vesting schedule encourages continued service and commitment from the director to StableX Technologies, Inc.

Negatives

• There is a potential for minor future share dilution if the options are exercised.

Risks

• The value of the options is dependent on the future stock price of StableX Technologies, Inc. If the stock price does not exceed the exercise price of $6.25, the options may expire worthless.
• The vesting of the remaining 25% of options is subject to a service condition, meaning they will not vest if the reporting person ceases employment or services before December 31, 2025.

Future Outlook

The remaining 25% of the granted stock options are scheduled to vest on December 31, 2025, contingent upon Joseph Zvi's continued employment or service to StableX Technologies, Inc.

Industry Context

The granting of stock options is a common practice in corporate compensation, particularly for directors and executives, to align their financial interests with the long-term performance of the company and its shareholders. This practice is prevalent across various industries, especially in technology sectors, to attract and retain talent.

Comparison to Industry Standards

• Stock option grants are a standard component of executive and director compensation packages across many publicly traded companies, including those in the technology sector.
• While the specific number of options (22,723) and exercise price ($6.25) are unique to StableX Technologies, Inc. and Joseph Zvi, the mechanism of granting options with a vesting schedule is a widely accepted practice.
• Similar equity compensation structures are observed at comparable companies in the technology space, where aligning management incentives with shareholder value is a key objective.

Related Party Transactions

• The grant of employee stock options to Joseph Zvi, a Director of StableX Technologies, Inc., constitutes a related party transaction as it involves compensation provided by the issuer to a member of its board of directors.

Stakeholder Impact

• Shareholders: Potential for minor future dilution if options are exercised, but also increased alignment of the director's interests with shareholder value creation.
• Director (Joseph Zvi): Receives equity-based compensation, providing a financial incentive tied to the company's stock performance and continued service.

Next Steps

• The remaining 25% of the stock options are expected to vest on December 31, 2025, subject to the reporting person's continued service.

Key Dates

Keywords

StableX Technologies, SBLX, Joseph Zvi, Stock Options, Director Compensation, Insider Transaction, Equity Grant, Vesting, SEC Form 4